Effects of LncRNA UNC5B-AS1 on adhesion, invasion and migration of lung cancer cells and its mechanism

doi:10.12047/j.cjap.5993.2020.130

Abstract

Abstract: Objective: To investigate the effects of long-chain non-coding RNA (lncRNA) UNC5B-AS1 on the adhesion, invasion and migration of lung cancer cells by regulating the expression of miR-218-5p. Methods: Twenty specimens of lung cancer patients and corresponding paracancerous tissues were surgically removed and collected from the oncology department of Chongqing Three Gorges Central Hospital from June 2017 to June 2019. Real-time quantitative PCR (qRT-PCR) was used to detect the expressions of UNC5B-AS1 in human bronchial epithelial cells HBE and different lung cancer cells of A549, H1437, H1975, H1299 and H460. UNC5B-AS1 siRNA was transfected into lung cancer A549 cells. Adhesion assay, transwell invasion assay and scratch assay were used to detect the effect of UNC5B-AS1 on adhesion, invasion and migration of A549 cells. qRT-PCR and dual luciferase reporter gene were used for the detection and identification of UNC5B-AS1 targeting miR-218-5p. The expression of epithelial-mesenchymal transition (EMT)-related protein was detected by Western blot. Results: The expression of UNC5B-AS1 in lung cancer tissues and cells was significantly higher than that in adjacent tissues and bronchial epithelial cells (P＜0.05). The expression of UNC5B-AS1 in lung cancer A549 cells was the highest (P＜0.05). Down-regulation of UNC5B-AS1 expression inhibited adhesion, invasion and migration of A549 cells (P＜0.05). qRT-PCR and dual luciferase reporter assay experiments showed that UNC5B-AS1 targeted the regulation of miR-218-5p expression. Down-regulation of UNC5B-AS1 inhibited E-cadherin protein expression and promoted Vimentin and Twist protein expression. Conclusion: lncRNA UNC5B-AS1 promotes adhesion, invasion and migration of lung cancer cells through targeted regulation of miR-218-5p expression, and its mechanism may be related to the promotion of EMT.

Key words: UNC5B-AS1, miR-218-5p, lung cancer cells, adhesion, invasion, migration

CLC Number:

R734.2

TAN Jian-Jun, LONG Shu-Zi, ZHANG Tao. Effects of LncRNA UNC5B-AS1 on adhesion, invasion and migration of lung cancer cells and its mechanism[J]. CJAP, 2020, 36(6): 622-627.

References

[1] Lipfert FW, Wyzga RE. Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis[J]. Crit Rev Toxicol, 2019, 49(9): 790-818.
[2] Skinner KE, Fernandes AW, Walker MS, et al. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study[J]. J Med Econom, 2017, 21(2): 1-9.
[3] Hao NB, He YF, Li XQ, et al. The role of miRNA and lncRNA in gastric cancer[J]. Oncotarget, 2017, 8(46): 81572-81582.
[4] Chen R, Li WX, Sun Y, et al. Comprehensive analysis of lncRNA and mRNA expression profiles in lung cancer[J]. Clin Lab, 2017, 63(2): 313-320.
[5] 王亚芳, 卢强, 赵晋波, 等. 小细胞肺癌组织中lncRNA表达谱的差异[J]. 现代肿瘤医学, 2014, 22(6): 1231-1235.
[6] Yang Q, Li J, Hu Y, et al. MiR-218-5p suppresses the killing effect of natural killer cell to lung adenocarcinoma by targeting SHMT1[J]. Yonsei Med J, 2019, 60(6): 500-508.
[7] Peng P, Chen T, Wang Q, et al. Decreased miR-218-5p levels as a serum biomarker in bone metastasis of prostate cancer[J]. Oncol Res Treat, 2019, 42(4): 165-185.
[8] Xu Y, He Q, Lu Y, et al. MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-κB signaling pathway[J]. Cancer Cell Int, 2018, 18: 198.
[9] Dama E, Melocchi V, Dezi F, et al. An aggressive subtype of stage I lung adenocarcinoma with molecular and prognostic characteristics typical of advanced lung cancers[J]. Clin Cancer Res, 2017, 23(1): 62-72.
[10] Cui Y, Zhang F, Zhu C, et al. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway[J]. Oncotarget, 2017, 8(11): 17785-17794.
[11] Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22(2): 443-449.
[12] Liao Y, Cheng S, Xiang J, et al. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients[J]. Eur Rev Med Pharmacol Sci, 2018, 22(6): 1686-1692.
[13] Kong C, Zhan B, Piao C, et al. Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice[J]. BMC Cancer, 2016, 16(1): 892-899.
[14] Hou S, Lin Q, Guan F, et al. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p[J]. J Cell Biochem, 2018, 119(10): 8304-8316.
[15] 张佳润, 孔垂泽, 高植鹏. UNC5B癌生物学功能的研究进展[J]. 现代肿瘤医学, 2017, 25(18): 3023-3026.
[16] Wang YH, Bhandari A, Niu JZ, et al. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines[J]. Biosci Rep, 2019, 32(3): 334-342.
[17] 沈钲杰, 朱银银, 沈凡含, 等. lncRNA与miRNA调节关系和ceRNA关系在疾病中的研究进展[J]. 中国细胞生物学学报, 2018, 40(10): 160-166.
[18] Zhu K, Ding H, Wang W, et al. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer[J]. Oncotarget, 2016, 7(19): 28075-28085.
[19] Liu M, Yin K, Guo X, et al. Diphthamide biosynthesis 1 is a novel oncogene in colorectal cancer cells and is regulated by miR-218-5p[J]. Cell Physiol Biochem, 2017, 44(2): 505-514.
[20] 陈育娟, 吴培阳, 高瑞秋. MiR-218对滋养层细胞迁移侵袭的影响及其机制研究[J]. 中国应用生理学杂志, 2017, 33(2): 169-173.
[21] 李先伟, 蒋莉莉, 左东泽, 等. 降钙素基因相关肽对大鼠肺泡上皮Ⅱ型细胞间质转分化的作用及机制[J]. 中国应用生理学杂志, 2018, 34(3): 249-253.